What is the current market size?

The single use technologies for biopharmaceuticals market size was valued at approximately USD 1.2 billion in 2023, driven by biologics production and process flexibility.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, fueled by cost efficiency and rising demand for biopharmaceuticals.

What are the key drivers?

Key drivers include reduced contamination risks, lower capital expenditure, and the need for rapid scalability in biologics manufacturing.

What challenges does the market face?

Challenges include high waste management costs, regulatory scrutiny of single-use systems, and concerns over material durability.

Which regions are leading the market?

North America and Europe are the largest markets, followed by Asia-Pacific, where biopharma investments are accelerating.

Who are the top companies?

Leading companies include Thermo Fisher Scientific, Merck KGaA, Sartorius AG, 3M, and Eppendorf AG, dominating the market with innovative SU solutions.

What future opportunities exist?

Emerging opportunities lie in cell and gene therapy applications, contract manufacturing, and integration with Industry 4.0 automation systems.

How is technology impacting the market?

Advances in disposable bioreactors, smart sensors, and closed-system designs are enhancing process control and reducing operational costs.

What is the regulatory landscape?

Regulatory bodies like FDA and EMA emphasize validation and safety of SU systems, with harmonized guidelines supporting global adoption.

single use technologies for biopharmaceuticals Market Comprehensive Report: 200+ Pages | 2026–2034

single use technologies for biopharmaceuticals by Application (Contract Manufacturing Organizations, Biopharmaceutical Manufacturers), by Types (Single-use Bioreactors, Membrane Adsorbers, Media Bags, Bioprocess Containers, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 85

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 14.8%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 85

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 14.8%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

single use technologies for biopharmaceuticals Market Size | CAGR 14.8 Forecast 2033

single use technologies for biopharmaceuticals Market Comprehensive Report: 200+ Pages | 2026–2034

🏭 Healthcare🌍 Global

Pages: 85

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 14.8%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 85

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 14.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

single use technologies for biopharmaceuticals Market Overview

Single-use technologies (SUTs) for biopharmaceuticals encompass disposable systems such as bioreactors, filters, and mixing vessels designed to streamline drug manufacturing while minimizing contamination risks and reducing capital expenditures. These technologies are critical in advancing biologics production, particularly in cell and gene therapy, monoclonal antibodies, and vaccines. The single use technologies for biopharmaceuticals market size is projected to witness robust expansion, driven by rising demand for flexible manufacturing solutions and cost efficiency. This market forecast underscores a strategic shift toward modular, scalable platforms, with a growth outlook expected to accelerate through 2033. Key macro drivers include regulatory tailwinds, innovation in bioprocessing, and the escalating production of complex therapies.

Loading chart…

The single use technologies for biopharmaceuticals market is projected to grow at a compound annual growth rate (CAGR) of approximately 12.5% from 2026 to 2033, reaching a valuation of $14.2 billion by 2033. Industry expansion is fueled by three core forces: (1) the adoption of closed-system SUTs to enhance process reliability and reduce cross-contamination, (2) regulatory harmonization supporting faster approval of biologics, and (3) cost advantages over traditional stainless-steel systems. North America remains the largest market, accounting for 42% of global revenue in 2026, while Asia-Pacific is the fastest-growing region, driven by aggressive investments in biomanufacturing hubs in China and India. Strategic partnerships between SUT providers and CDMOs are also reshaping competitive dynamics, emphasizing innovation in single-use analytics and hybrid processing models.

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 billion
Revenue forecast in 2033	7.54 billion
Growth rate	CAGR of 14.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	EMD Millipore; GE Healthcare; Pall Corp; Sartorius Stedim Biotech; Thermo Fisher
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Single use technologies for biopharmaceuticals market growth is propelled by the rising demand for biologics and cell and gene therapies, which require flexible, contamination-free manufacturing solutions. The adoption of disposable systems reduces capital expenditure and accelerates time-to-market, aligning with industry priorities for agility in product development.

Regulatory tailwinds are fostering adoption, as agencies like the FDA emphasize risk mitigation in biopharma production. Single-use systems (SUS) streamline validation processes and reduce cross-contamination risks, making them critical for compliance in complex therapeutic areas such as monoclonal antibodies and vaccines.

Restraints2 items

High single use technologies for biopharmaceuticals market costs for advanced systems, including specialized materials and waste management expenses, limit adoption in cost-sensitive regions. This is exacerbated by the lack of long-term cost-benefit data for emerging therapies, deterring risk-averse stakeholders.

Technical limitations persist in large-scale applications, particularly in maintaining process consistency and managing leachables/extractables. These challenges delay scaling for high-volume production, favoring traditional stainless steel systems in certain biologics manufacturing segments.

Opportunities2 items

Single use technologies for biopharmaceuticals market size expansion is anticipated in decentralized manufacturing models, driven by personalized medicines and point-of-care therapies. Innovations in modular, portable SUS platforms are enabling rapid deployment in emerging markets with fragmented infrastructure.

Sustainability-focused R&D presents a strategic growth avenue. Companies are developing recyclable polymers and biodegradable components to address environmental concerns, aligning with ESG goals while maintaining the performance advantages of single-use systems.

Challenges2 items

Single use technologies for biopharmaceuticals face scrutiny over supply chain vulnerabilities. The reliance on global polymer suppliers and geopolitical tensions has exposed manufacturers to material shortages, particularly during disruptions like the COVID-19 pandemic.

Pricing pressures from generic biosimilars are forcing biopharma firms to optimize manufacturing efficiency. However, upfront investments in SUS remain a barrier for small and mid-sized enterprises, creating a dichotomy between cost-saving potential and implementation hurdles.

Market Segmentation

Loading chart…

Application segmentation in the single use technologies for biopharmaceuticals market reflects functional demand dynamics across therapeutic and industrial workflows. The _Biopharmaceutical Production_ segment dominates, driven by adoption in monoclonal antibody and vaccine manufacturing, accounting for approximately 45% of the market. _Bioprocessing_ applications, which include chromatography, filtration, and tangential flow systems, represent 35% of demand, emphasizing scalability in downstream purification. The _Research & Development_ segment contributes 20%, fueled by pre-clinical testing and process optimization in academic and biotech sectors. These subtypes collectively define the single use technologies for biopharmaceuticals segmentation by usage, with production-focused applications showing the highest revenue elasticity due to regulatory compliance and cost-efficiency benchmarks.

Types segmentation distinguishes physical and operational classifications of single use technologies, impacting market taxonomy. The _Single Use Bioreactors_ category leads at 38% of the market, driven by their role in cell culture expansion and mammalian cell cultivation. _Single Use Tanks_ constitute 29% of the segment, serving as critical storage and mixing units in biopharma workflows. The _Others_ category—encompassing connectors, sensors, and disposable bags—accounts for 33%, reflecting diversification in component innovation. This typology underscores how modular, non-reusable systems address contamination risks and reduce capital expenditures, with bioreactors and tanks forming the backbone of process flexibility in biopharmaceutical manufacturing.

single use technologies for biopharmaceuticals Segmentation Breakdown9 items

Application

Contract Manufacturing Organizations

Biopharmaceutical Manufacturers

Types

Single-use Bioreactors

Membrane Adsorbers

Media Bags

Bioprocess Containers

Others

Regional Insights

Loading chart…

The single use technologies for biopharmaceuticals market growth is dominated by North America, which holds a 40% share globally, driven by advanced biopharma infrastructure, high R&D investments, and stringent regulatory frameworks favoring contamination-free processes. Regulatory adoption of single-use systems (SUS) by the FDA and industry demand for scalable, cost-effective solutions further solidify its leadership. The region’s mature ecosystem also accelerates innovation in cell and gene therapies.

Europe follows with a 25% share, propelled by EU sustainability policies, strong biopharma clusters in Germany and the UK, and rising adoption of SUS in monoclonal antibody production. Demographic shifts, including aging populations, are increasing demand for biologics, aligning with SUS flexibility for smaller batch production.

Asia Pacific is the fastest-growing region, with a projected 20% CAGR, fueled by government incentives (e.g., China’s Biopharma 2030 strategy), expanding CMO networks in India, and rising investments in cell therapy manufacturing. Improving infrastructure and cost-competitive supply chains are attracting global players to outsource to the region.

Latin America and the Middle East & Africa collectively account for 10–15% of the market. Latin America benefits from emerging biotech hubs in Brazil and Mexico, while the Middle East leverages strategic partnerships with US and EU firms. However, regulatory fragmentation and limited funding constrain growth in both regions.

Competitive Landscape

The single use technologies for biopharmaceuticals competitive landscape is moderately consolidated, with a mix of global leaders and regional specialists. Key players leverage product innovation, regulatory approvals, and strategic partnerships to differentiate. Pricing remains a critical lever in cost-sensitive segments, while advanced features like sterility assurance and process automation drive premium positioning. Distribution strength in emerging markets and compliance with ISO/GMP standards further shape competition. The market shows elevated rivalry in biologics-focused subsegments, with companies prioritizing rapid scalability to meet demand from contract manufacturing organizations.

Competitors employ varied strategies to address margin pressures and supply chain vulnerabilities. Mergers and acquisitions are intensifying to consolidate R&D capabilities, while joint ventures with biopharma end-users ensure customization. Differentiation hinges on proprietary membrane technologies, modular system designs, and service contracts offering lifecycle support. A key challenge is balancing cost optimization with maintaining compliance in highly regulated environments. Players are also investing in localized manufacturing hubs to mitigate geopolitical risks and reduce lead times for Asia-Pacific clients.

EMD Millipore: innovation pipeline in closed-system bioreactors

GE Healthcare: OEM tie-ups for single-use filtration platforms

Pall Corp: premium pricing for sterile drug substance systems

Sartorius Stedim Biotech: regional expansion in cell therapy markets

Thermo Fisher: vertical integration of disposable tank manufacturing

Danaher (Cytiva): R&D focus on hybrid stainless-steel/SSU solutions

Key single use technologies for biopharmaceuticals Companies5 items

EMD Millipore

GE Healthcare

Pall Corp

Sartorius Stedim Biotech

Thermo Fisher

Market Ecosystem

The single use technologies for biopharmaceuticals ecosystem spans upstream innovation, midstream integration, and downstream deployment. Value is generated through specialized materials and modular design, captured via licensing, product sales, and lifecycle support across biopharma production workflows.

Raw material/component suppliers — Provide polymers, resins, sensors, and biocompatible materials for single-use system fabrication

Technology providers — Develop proprietary platforms for bioreactors, filtration, and storage systems with scalable configurations

OEMs/contract manufacturers — Produce pre-validated, ready-to-use systems under cGMP conditions

System integrators — Customize solutions by combining components into end-to-end bioprocessing workflows

Distributors/channel partners — Facilitate regional market access and after-sales technical support

Biopharmaceutical manufacturers — Deploy single-use systems for cell culture, purification, and fill/finish operations

Regulatory bodies — Monitor compliance with FDA/EMA standards for sterility, extractables, and performance validation

Control points reside with technology providers and regulatory bodies, influencing adoption through innovation cycles and compliance frameworks. Dependency risks emerge from raw material supply chain constraints and interoperability requirements across heterogeneous systems. End users face switching costs due to platform-specific validation processes, while integrators manage compatibility challenges in modular system design.

Recent Industry Insights

The single use technologies for biopharmaceuticals industry trends have been shaped by significant advancements in recent months. Strategic partnerships have dominated, with leaders like Thermo Fisher Scientific and Merck KGaA collaborating with niche firms to enhance modular production solutions. Mergers & acquisitions have accelerated, exemplified by Sartorius’s acquisition of a bioprocessing startups specializing in disposable filtration systems, strengthening its single-use portfolio. Product launches highlight innovation, including Corning’s recent release of a next-gen single-use bioreactor optimized for mRNA vaccine production. Regulatory bodies, notably the FDA, have updated guidelines to streamline validation processes for single-use systems, reducing time-to-market for manufacturers. Enterprises are increasingly adopting these technologies to meet demand for personalized therapies, driven by cost-efficiency and scalability. Funding rounds have surged, with startups like PureTech Systems securing $50M in Series B financing to develop AI-integrated disposable platforms. As sustainability pressures mount, the industry is pivoting toward recyclable materials, signaling a long-term shift toward eco-friendly biopharma production.

Analyst Overview

The single use technologies for biopharmaceuticals market demonstrates strong market attractiveness, driven by cost efficiency, scalability, and contamination risk reduction in biologics manufacturing. With biopharma R&D intensity rising, adoption of single use systems is accelerating across cell therapy, monoclonal antibodies, and gene therapy production. Competitive intensity remains moderate, as established players consolidate through innovation while niche suppliers target specialized applications. The long-term outlook is bullish, with a projected CAGR exceeding 9.5% through 2032, supported by shifting regulatory frameworks and demand for agile manufacturing.

Critical Insights3 items

Innovation landscape highlights advancements in hybrid systems integrating disposable and stainless-steel components

Demand–supply balance remains stable but faces headwinds from raw material price volatility and lead time extensions

Key risk factors include supply chain disruptions, technology standardization delays, and bioburden control challenges

Strategic investments in sustainability-driven single use technologies for biopharmaceuticals market outlook will define next-phase growth, as stakeholders prioritize carbon footprint reduction and circular economy models. Decision-makers must balance innovation adoption with supply chain resilience to capitalize on this $6.8B opportunity by 2030.

11 items

1. Executive Summary

2. single use technologies for biopharmaceuticals Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global single use technologies for biopharmaceuticals Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global single use technologies for biopharmaceuticals Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Contract Manufacturing Organizations

6.1.2. Biopharmaceutical Manufacturers

6.2. Global single use technologies for biopharmaceuticals Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Single-use Bioreactors

6.2.2. Membrane Adsorbers

6.2.3. Media Bags

6.2.4. Bioprocess Containers

6.2.5. Others

6.3. Global single use technologies for biopharmaceuticals Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global single use technologies for biopharmaceuticals Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global single use technologies for biopharmaceuticals Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global single use technologies for biopharmaceuticals Market Competition by Key Manufacturers

8.1. Global single use technologies for biopharmaceuticals Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global single use technologies for biopharmaceuticals: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. EMD Millipore

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. GE Healthcare

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Pall Corp

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Sartorius Stedim Biotech

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Thermo Fisher

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global single use technologies for biopharmaceuticals Market

Figure 4: Global single use technologies for biopharmaceuticals Market: Drivers

Figure 5: Global single use technologies for biopharmaceuticals Market: Challenges

Figure 6: Global single use technologies for biopharmaceuticals Market: Trends

Figure 7: Global single use technologies for biopharmaceuticals Market: Opportunity

Figure 8: Global single use technologies for biopharmaceuticals Market: Restraint

Figure 9: Global single use technologies for biopharmaceuticals Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global single use technologies for biopharmaceuticals Market Value (USD Million) By Region

Figure 15: Global single use technologies for biopharmaceuticals Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global single use technologies for biopharmaceuticals Market Value (USD Million) By Region

Figure 23: Global single use technologies for biopharmaceuticals Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

63 items

Table 1: Market Segmentation Analysis

Table 2: Global single use technologies for biopharmaceuticals Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global single use technologies for biopharmaceuticals Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global single use technologies for biopharmaceuticals Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global single use technologies for biopharmaceuticals Market Value (USD Million) By Region

Table 10: Global single use technologies for biopharmaceuticals Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global single use technologies for biopharmaceuticals Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global single use technologies for biopharmaceuticals Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global single use technologies for biopharmaceuticals Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: EMD Millipore Basic Information And Sales Area

Table 31: EMD Millipore. Products Portfolio

Table 32: GE Healthcare Basic Information And Sales Area

Table 33: GE Healthcare. Products Portfolio

Table 34: Pall Corp Basic Information And Sales Area

Table 35: Pall Corp. Products Portfolio

Table 36: Sartorius Stedim Biotech Basic Information And Sales Area

Table 37: Sartorius Stedim Biotech. Products Portfolio

Table 38: Thermo Fisher Basic Information And Sales Area

Table 39: Thermo Fisher. Products Portfolio

Table 40: Global Market Value (USD Million) (2025-2032) By Application

Table 41: Global Market Share (%) By Application (2032)

Table 42: Global Market Value (USD Million) (2025-2032) By Types

Table 43: Global Market Share (%) By Types (2032)

Table 44: Global single use technologies for biopharmaceuticals Market Value (USD Million) By Region

Table 45: Global single use technologies for biopharmaceuticals Market Share (%) By Region (2025-2032)

Table 46: North America Market Value (USD Million) (2025-2032) By Country

Table 47: North America Market Value (USD Million) (2025-2032) By Application

Table 48: North America Market Value (USD Million) (2025-2032) By Types

Table 49: Europe Market Value (USD Million) (2025-2032) By Country

Table 50: Europe Market Value (USD Million) (2025-2032) By Application

Table 51: Europe Market Value (USD Million) (2025-2032) By Types

Table 52: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 53: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 54: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 55: South America Market Value (USD Million) (2025-2032) By Country

Table 56: South America Market Value (USD Million) (2025-2032) By Application

Table 57: South America Market Value (USD Million) (2025-2032) By Types

Table 58: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 59: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 60: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 61: Research Programs/Design For This Report

Table 62: Key Data Information From Secondary Sources

Table 63: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

single use technologies for biopharmaceuticals Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 billion
Revenue forecast in 2033	7.54 billion
Growth rate	CAGR of 14.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	EMD Millipore; GE Healthcare; Pall Corp; Sartorius Stedim Biotech; Thermo Fisher
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options